- Home
- CSBR vs FCEL Comparison
CSBR vs FCEL Comparison
Compare CSBR & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CSBR | FCEL |
|---|---|---|
| Founded | 1985 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.0M | 398.1M |
| IPO Year | 1986 | 1992 |
Fundamental Metrics
Financial Performance| Metric | CSBR | FCEL |
|---|---|---|
| Price | $6.75 | $7.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $12.00 | $9.08 |
| AVG Volume (30 Days) | 21.7K | ★ 2.7M |
| Earning Date | 12-15-2025 | 12-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $58,424,000.00 | ★ $158,162,000.00 |
| Revenue This Year | $4.84 | $15.27 |
| Revenue Next Year | $11.51 | $37.39 |
| P/E Ratio | $38.91 | ★ N/A |
| Revenue Growth | 9.06 | ★ 41.05 |
| 52 Week Low | $5.59 | $3.58 |
| 52 Week High | $11.99 | $13.98 |
Technical Indicators
Market Signals| Indicator | CSBR | FCEL |
|---|---|---|
| Relative Strength Index (RSI) | 50.08 | 46.74 |
| Support Level | $6.52 | $7.14 |
| Resistance Level | $6.79 | $8.54 |
| Average True Range (ATR) | 0.37 | 0.81 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 46.22 | 15.54 |
Price Performance
Historical ComparisonAbout CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.